[HTML][HTML] Viral hepatitis: Past, present, and future
Each hepatitis virus—Hepatitis A, B, C, D, E, and G—poses a distinct scenario to the patient
and clinician alike. Since the discovery of each virus, extensive knowledge regarding …
and clinician alike. Since the discovery of each virus, extensive knowledge regarding …
Infectious disease transmission in solid organ transplantation: donor evaluation, recipient risk, and outcomes of transmission
SL White, W Rawlinson, P Boan… - Transplantation …, 2019 - journals.lww.com
Abstract In 2016, the Transplantation Society of Australia and New Zealand, with the support
of the Australian Government Organ and Tissue authority, commissioned a literature review …
of the Australian Government Organ and Tissue authority, commissioned a literature review …
Heart and lung transplants from HCV-infected donors to uninfected recipients
AE Woolley, SK Singh, HJ Goldberg… - … England Journal of …, 2019 - Mass Medical Soc
Background Hearts and lungs from donors with hepatitis C viremia are typically not
transplanted. The advent of direct-acting antiviral agents to treat hepatitis C virus (HCV) …
transplanted. The advent of direct-acting antiviral agents to treat hepatitis C virus (HCV) …
Trial of transplantation of HCV-infected kidneys into uninfected recipients
DS Goldberg, PL Abt, EA Blumberg… - … England Journal of …, 2017 - Mass Medical Soc
Trial of Transplantation of HCV-Infected Kidneys into Uninfected Recipients | New England
Journal of Medicine Skip to main content The New England Journal of Medicine homepage …
Journal of Medicine Skip to main content The New England Journal of Medicine homepage …
Direct-acting antiviral prophylaxis in kidney transplantation from hepatitis C virus–infected donors to noninfected recipients: an open-label nonrandomized trial
Background: Given the high mortality rate for patients with end-stage kidney disease
receiving dialysis and the efficacy and safety of hepatitis C virus (HCV) treatments …
receiving dialysis and the efficacy and safety of hepatitis C virus (HCV) treatments …
[HTML][HTML] The American Society of Transplantation Consensus Conference on the use of hepatitis C viremic donors in solid organ transplantation
The availability of direct-acting antiviral agents for the treatment of hepatitis C virus (HCV)
infection has resulted in a profound shift in the approach to the management of this infection …
infection has resulted in a profound shift in the approach to the management of this infection …
Twelve-month outcomes after transplant of hepatitis C–infected kidneys into uninfected recipients: a single-group trial
PP Reese, PL Abt, EA Blumberg… - Annals of internal …, 2018 - acpjournals.org
Background: Organs from hepatitis C virus (HCV)–infected deceased donors are often
discarded. Preliminary data from 2 small trials, including THINKER-1 (Transplanting …
discarded. Preliminary data from 2 small trials, including THINKER-1 (Transplanting …
Factors leading to the discard of deceased donor kidneys in the United States
The proportion of deceased donor kidneys procured for transplant but subsequently
discarded has been growing steadily in the United States, but factors contributing to the …
discarded has been growing steadily in the United States, but factors contributing to the …
The drug overdose epidemic and deceased-donor transplantation in the United States: a national registry study
Background: The epidemic of drug overdose deaths in the United States has led to an
increase in organ donors. Objective: To characterize donors who died of overdose and to …
increase in organ donors. Objective: To characterize donors who died of overdose and to …
Transplantation of kidneys from hepatitis C–infected donors to hepatitis C–negative recipients: Single center experience
Our aim was to evaluate the safety of transplanting kidneys from HCV‐infected donors in
HCV‐uninfected recipients. Data collected from 53 recipients in a single center …
HCV‐uninfected recipients. Data collected from 53 recipients in a single center …